Case of Vasculitic Neuropathy and Myelopathy

Authors

  • Mai Yamakawa, MD University of Kansas Medical Center, Department of Neurology, Kansas City, KS, USA
  • Mamatha Pasnoor, MD University of Kansas Medical Center, Department of Neurology, Kansas City, KS, USA

DOI:

https://doi.org/10.17161/rrnmf.v3i2.15879

Keywords:

Vasculitic neuropathy, Inflammatory neuropathy

Abstract

N/A

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

Author Biography

  • Mamatha Pasnoor, MD, University of Kansas Medical Center, Department of Neurology, Kansas City, KS, USA

    Department of Neurology, Professor

References

REFERENCES

Selva-O’Callaghan A, Alvarado-Cardenas M, Pinal-Fernández I, Trallero-Araguás E, Milisenda JC, Martínez MÁ, et al. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol. 2018;14:215–24.

Wludarczyk A, Szczeklik W. Neurological manifestations in ANCA-associated vasculitis - assessment and treatment. Expert Rev Neurother. 2016;16:861–3. doi:10.1586/14737175.2016.1165095.

Koppikar S, Al-Dabie G, Jerome D, Vinik O. Eosinophilic granulomatosis with polyangiitis presenting with myositis: case based review. Rheumatol Int. 2020;40:1163–70.

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.

Chakraborty RK, Aeddula NR. Churg Strauss Syndrome. Treasure Island (FL); 2020.

Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008;67:1004–10.

Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44:666–75.

Cohen P, Pagnoux C, Mahr A, Arène J-P, Mouthon L, Le Guern V, et al. Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum. 2007;57:686–93.

Ribi C, Cohen P, Pagnoux C, Mahr A, Arène J-P, Lauque D, et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum. 2008;58:586–94.

Radić M, Martinović Kaliterna D, Radić J. Drug-induced vasculitis: a clinical and pathological review. Neth J Med. 2012;70:12–7.

Wiik A. Drug-induced vasculitis. Curr Opin Rheumatol. 2008;20:35–9.

Sheoran A, Mahto SK, Verma P, War GA, Agarwal N, Singh A. Leukocytoclastic vasculitis: An uncommon adverse effect of a common drug. Journal of family medicine and primary care. 2019;8:2137–9.

Downloads

Published

2022-06-22

Issue

Section

Clinic Stuff (Case Reports)

How to Cite

Yamakawa, M., & Pasnoor, M. (2022). Case of Vasculitic Neuropathy and Myelopathy. RRNMF Neuromuscular Journal, 3(2), 34-37. https://doi.org/10.17161/rrnmf.v3i2.15879